Localization Defines Streptozotocin/5-FU Response in Primary Pancreatic Neuroendocrine Tumours

<b><i>Introduction:</i></b> Incidence of pancreatic neuroendocrine tumours (pNETs) is on the rise. The only curative treatment is surgical resection in localized or oligo-metastatic disease. However, patients may present with locally advanced or unresectable primary tumours. So far, no conversion therapy to achieve resectability has been established, which is partly due to lack of data on primary tumour response to...